Header cover image

U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

UPDATED May 02, 2024

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

676 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

YMTX

Yumanity Therapeutics		US$13.23-8.3%-41.3%US$143.6mn/aPS29.7xn/an/a

KDNY

Chinook Therapeutics		US$40.390.3%95.7%US$2.9bUS$40.09PS495.8xE22.6%n/a

EQRX

EQRx		US$2.34-5.3%-36.2%US$1.1bn/aPB1xS123.3%n/a

TALS

Talaris Therapeutics		US$27.20-4.9%91.5%US$553.2mUS$200.00PB3.7xn/an/a

GRPH

Graphite Bio		US$22.26539.7%861.6%US$190.4mn/aPB7.1xE36.4%n/a

NGM

NGM Biopharmaceuticals		US$1.54-3.1%-59.8%US$128.5mUS$1.55PS29.1xE14.7%n/a

FDMT

4D Molecular Therapeutics		US$26.3812.1%64.1%US$1.3bUS$54.22PS65.1xE-1.9%n/a

DRMA

Dermata Therapeutics		US$0.340%-78.5%US$2.2mUS$1.50PB0.4xE-19.3%n/a

ALVR

AlloVir		US$0.810.8%-81.1%US$90.4mUS$1.00PB0.6xE33.8%n/a

PMCB

PharmaCyte Biotech		US$2.161.9%-22.6%US$18.0mn/aPB0.6xn/an/a

CORT

Corcept Therapeutics		US$25.0612.8%4.4%US$2.5bUS$43.60PE22.2xE24.8%n/a

OLMA

Olema Pharmaceuticals		US$10.072.4%58.6%US$581.7mUS$25.00PB2.2xE8.1%n/a

OLK

Olink Holding		US$23.02-0.2%3.6%US$2.8bUS$26.00PS16.9xE61.0%n/a

VNDA

Vanda Pharmaceuticals		US$4.684.5%-31.9%US$277.6mUS$5.21PE108.6xE2.4%n/a

TRVI

Trevi Therapeutics		US$3.0118.5%-5.9%US$201.4mUS$7.40PB2.6xE-9.6%n/a

BRNS

Barinthus Biotherapeutics		US$2.15-11.7%-9.1%US$85.6mUS$7.40PS104.1xE-12.6%n/a

TRML

Tourmaline Bio		US$15.92-0.5%n/aUS$402.9mUS$58.33PB2xE-13.4%n/a

NRIX

Nurix Therapeutics		US$12.733.0%34.9%US$775.9mUS$25.09PS9.3xE-4.1%n/a

ATXS

Astria Therapeutics		US$9.352.0%-26.1%US$521.7mUS$25.29PB3.5xE28.2%n/a

GHRS

GH Research		US$11.196.6%28.8%US$621.7mUS$31.75PB2.7xE-17.5%n/a

FRTX

Fresh Tracks Therapeutics		US$0.91-1.1%65.4%US$5.6mn/aPB0.5xn/an/a

SWTX

SpringWorks Therapeutics		US$43.35-1.9%83.4%US$3.5bUS$67.66PS120.7xE45.4%n/a

TNYA

Tenaya Therapeutics		US$4.629.5%-20.8%US$367.5mUS$19.43PB2.6xE52.1%n/a

ELTX

Elicio Therapeutics		US$9.00-1.1%n/aUS$90.5mUS$10.00PB8.1xn/an/a
Page 1 of 29
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.